AlphAIAlphAI — Financial news for AI agents
stocktitan.netSEP 161 min read$ALHC

Alignment Healthcare (NASDAQ: ALHC) director plans tax-cover sale of 26,000 shares

Alignment Healthcare (ALHC) director and EVP Joseph Konowiecki filed a Rule 144 notice to sell 26,000 shares, valued at $226,460, to cover tax obligations on vested equity awards. The sale is scheduled for September 17, 2026, and is not discretionary. Konowiecki also reported prior sales of 75,000 shares under a 10b5-1 plan.

Original reporting
stocktitan.net
Published Sep 16, 2026, 9:57 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 16, 2026, 10:49 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefFinancial news
Primary signal
$ALHC
Neutral
high confidence
Mentioned
$ALHC
Relevance
4/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$ALHCNeutralLow
01

Why it matters

The disclosed sale is routine and unlikely to move the stock significantly.

02

Market read

A small, tax-cover insider sale with limited market impact.

03

What to watch

Potential future insider sales under the same 10b5-1 plan could increase cumulative dilution.

Relevance 4/10Novelty 4/10Timing: sale scheduled for Sep 17, 2026

Background

Form 144 filings disclose planned insider sales to the market, providing transparency.

Company-level read

Ticker impact

$ALHCNeutralHigh confidence
Context

Director Joseph Konowiecki filed a Form 144 to sell 26,000 shares worth $226,460 to cover tax obligations.

Expected impact

Likely negligible effect on ALHC share price.

Evidence & confidence

The sale size is small relative to market cap and is a routine tax-cover transaction.

Market effects

Sector

No broader sector impact; specific to Alignment Healthcare.

Regional

None

Global

None

Counterpoint

What could challenge this read

If the market overreacts to any insider sale, a short position could be considered.

Key entities

  • Director & EVP
    Joseph Konowiecki

    Filed the Rule 144 notice for the share sale.

Read at source← All news

Related articles

SEP 16
$ALHCMed

Alignment Healthcare extends retreat, falls an additional 16% (ALHC:NASDAQ)

Alignment Healthcare (ALHC) shares fell 16% on Wednesday, extending a 20% drop from the prior session. Management cited planned investments and medical-cost pressures at the Baird 2026 Global Healthcare Conference. The stock reached a 52-week low at $8.71, trading 45-54% below its 50/200-day averages. An analyst upgraded ALHC to Buy, noting operational progress but warning of potential volatility.

seekingalpha.com1 min
SEP 15
$ASTHMed

Astrana Health, Clover Health, Alignment Healthcare, and Novavax Stocks Trade Down, What You Need To Know

Several healthcare stocks fell after bipartisan lawmakers introduced the Protecting Approved Care Act, which aims to reform Medicare Advantage plans. The bill could increase medical loss ratios and administrative burdens for insurers. Astrana Health (ASTH) fell 2.7%, Clover Health (CLOV) 4.8%, Alignment Healthcare (ALHC) 12.6%, and Novavax (NVAX) 3.6%.

financialcontent.com2 min
SEP 15
$ALHCMed

ALHC Stock Tumbles After ‘Don’t Poke the Bear’ Silence On Star Ratings — CLOV Falls With It

Alignment Healthcare (ALHC) shares dropped 22% after executives declined to discuss next year's quality bonus and noted higher-than-expected hospital bills. CEO John Kao cited CMS sensitivity about commenting on Plan Preview 2. Clover Health (CLOV) also fell 9%. ALHC's CFO mentioned institutional cost headwinds but expects them to ease by 2027. Guidance remained unchanged.

stocktwits.com2 min
SEP 10
$PGNYHighAI 8/10

Spotting Winners: Progyny (NASDAQ:PGNY) And Health Insurance Providers Stocks In Q2

Progyny (PGNY) and other health insurers reported Q2 earnings, with revenues beating estimates by 2.8% but guidance below expectations. PGNY's revenue grew 5.3% YoY, missing EBITDA guidance. CVS Health (CVS) reported 7.3% YoY revenue growth, beating estimates. Molina Healthcare (MOH) saw a 4.8% YoY revenue decline. Alignment Healthcare (ALHC) grew 31.6% YoY, while Clover Health (CLOV) saw 55.6% YoY growth. Stocks have declined since earnings, except CLOV, which rose 4.3%.

tradingview.com3 min
AUG 18
$ALHCMed

Alignment Health seeks to have former exec's whistleblower suit tossed

Alignment Healthcare and executives filed to dismiss a whistleblower suit by former exec Hakan Kardes, who alleges earnings were artificially boosted for higher bonuses. The company claims Kardes resigned voluntarily and his claims are false. Kardes says he was forced out after reporting accounting irregularities, affecting EBITDA and executive bonuses. Shares dropped initially but rebounded.

fiercehealthcare.com5 min
AUG 12
$ALHCMed

Alignment Healthcare (ALHC) Stock Drops 16.7% After Whistleblower Accounting Allegations Trigger Securities Investigation

Kaplan Fox & Kilsheimer LLP said it is investigating potential securities violations at Alignment Healthcare, Inc. (NASDAQ: ALHC) after a whistleblower complaint alleging accounting irregularities that allegedly inflated previously reported and projected results. The complaint cites operating expenses allegedly misclassified as capital expenditures, affecting Adjusted EBITDA. On July 8, 2026, ALHC shares fell $4.02, or 16.7%, to close at $20.03.

kalkine.ca3 min